New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2014
05:41 EDTAMAGAMAG Pharmaceuticals upgraded to Hold from Underperform at Jefferies
Jefferies upgraded AMAG Pharmaceuticals to Hold citing limited downside potential after the FDA issued a complete response letter for Feraheme broader use. The firm raised its price target for shares to $19 from $16.
News For AMAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
17:59 EDTAMAGAdage capital reports 10.7% passive stake in AMAG Pharmaceuticals
Subscribe for More Information
February 25, 2015
18:32 EDTAMAGAMAG Pharmaceuticals 3.98M share Secondary priced at $44.00
Subscribe for More Information
February 24, 2015
18:15 EDTAMAGOn The Fly: After Hours Movers
Subscribe for More Information
16:06 EDTAMAGAMAG Pharmaceuticals files to sell $125M in common stock
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use